# IPMS for a hospital or medical research institute: what changes

URL: https://zernyxhub.com/blog/ipms-for-hospitals
Author: Dr. Abhay Tharmatt, Research Scientist, R&D, Zernyx Innovations
Published: 2026-11-08
Category: Technology transfer

> Hospital IP management in India: how clinician inventors, patient data, ethics approvals, sample transfers and device rules change what an IPMS must track.

**Short answer:** Hospital IP management differs from a university's in five ways: inventors are busy clinicians, inventions often rest on patient data, ethics committee approvals must be linked to each project, biological samples move under material transfer agreements, and devices face medical device licensing. Under the DPDP Act, 2023, from May 2027 the institution stays responsible for personal data its processors handle.

A university IPR cell manages inventions from labs. A hospital or medical research institute manages inventions from wards, operating theatres, pathology labs and clinics. The inventor may be a surgeon with forty minutes free a week. The invention may depend on images from two thousand patients. The prototype may need an ethics committee's approval before it can be tested, and a licence from a drug regulator before it can be sold.

These differences change what an IP management system has to hold. A hospital that buys a system designed only for patent docketing ends up running the important parts in spreadsheets and email. This post explains the five things that change in a hospital, what each means for the records you keep, and how to set up IP management that fits.

## What changes in a hospital?

| Area | University lab | Hospital or medical research institute |
|---|---|---|
| Inventors | Faculty and students with research time | Clinicians with patient duties, often on rotating schedules |
| Data behind the invention | Lab measurements | Patient records, images and outcomes |
| Approvals | Biosafety, sometimes ethics | Ethics committee approval for most studies on people or their data |
| Materials | Chemicals, cell lines, strains | Patient samples, tissue and biological material |
| Route to market | Licence, then product development | Licence, then medical device or drug regulation |

Each row adds records that a hospital IPMS needs to link to the invention. The patent file is only one of them.

## Why does patient data matter for IP records?

Many hospital inventions rest on patient data: a diagnostic algorithm trained on scans, a surgical tool refined from outcome records, a risk score built from case notes. The invention disclosure and the patent application describe the invention, but the underlying data is personal data of patients.

The [Digital Personal Data Protection Act, 2023](https://www.meity.gov.in/static/uploads/2024/06/2bf1f0e9f04e6fb4f8fef35e82c42aa5.pdf) sets duties that follow that data. Under the DPDP Rules, 2025, these duties apply from May 2027, so plan for them now:

| Provision | What it says | What it means for IP management |
|---|---|---|
| Section 8(1) | The data fiduciary stays responsible for processing, including by its data processors | Using an outside IP system or service provider does not move responsibility for patient data |
| Section 8(5) | Reasonable security safeguards to prevent a personal data breach | IP records holding any patient data need proper access control |
| Section 8(6) | Breaches must be reported to the Board and affected individuals | A breach in an IP system containing patient data is reportable |

The simplest protection is to keep identifiable patient data out of IP records entirely. Disclosures should describe datasets in aggregate, refer to the ethics approval and data storage location, and never attach raw patient files. If you are choosing how to host an IP system, [cloud vs on-premise IPMS](https://zernyxhub.com/blog/cloud-vs-on-premise-ipms) sets out the security responsibilities on each side.

## What extra records should a hospital link to each invention?

| Record | Why it matters | When it is needed |
|---|---|---|
| Ethics committee approval number and scope | Shows the data or samples behind the invention were collected lawfully and for a purpose that covers this use | At disclosure, and in due diligence by a licensee |
| Data source and storage location | Lets the TTO answer licensee questions without moving data | At disclosure |
| Material transfer agreements | Controls use of patient samples sent to or received from partners | Before any sample moves |
| Inventor affiliations | Doctors may hold posts at a hospital, a medical college and a research council at once | At disclosure, to settle ownership |
| Conflict-of-interest declarations | Clinicians may advise or hold shares in companies | Before licensing |
| Device class and regulatory route | Sets the time and cost to market | Once the product form is clear |

Affiliation deserves a closer look. A consultant who also teaches at a medical college and holds a project grant from a research council may have three institutions with a claim on one invention. Settle it at disclosure, in writing, before a filing names the applicant.

Conflict of interest is common in hospitals. The [AIIMS IPR Policy 2017](https://www.aiims.edu/aiims/departments_17_5_16/IPR/01-IPR%20policy%202017-for%20upload.pdf), for example, requires inventors to disclose actual or potential conflicts, including stakes held by immediate family in a licensee company, and requires approval before licensing to such a company. It also requires an NDA or MTA before confidential information or research material leaves the institute.

**A hospital invention, from ward to licence**
1. Disclosure: No raw patient data; ethics approval linked
2. Ownership settled: Every affiliation and grant recorded
3. Filing decision: Patent, design or neither
4. Regulatory route mapped: Device class, licence path
5. Licence: Conflicts cleared first

## How does medical device regulation change the IP picture?

A licensee buying a hospital device technology is buying years of regulatory work as well as the patent. Under the Medical Devices Rules, 2017, most Class A and B devices are licensed by the State Licensing Authority, and Class C and D by CDSCO, often preceded by a test licence to make devices for testing and evaluation. [TRL for medical devices](https://zernyxhub.com/blog/trl-medical-devices) maps readiness levels to this path.

For the TTO, recording the likely device class and the evidence already available, such as bench tests, usability data or clinical observations, makes each technology far easier to market. A licensee will ask about the regulatory path in the first meeting.

## Why do clinician inventors need a different approach?

Clinicians rarely have time for long forms or meetings. A hospital TTO that wants disclosures should:

- Keep the disclosure form short, with the ethics and data questions built in.
- Accept disclosures in person or by phone, with the TTO completing the form.
- Give each inventor a simple view of where their invention stands; [inventor portal](https://zernyxhub.com/blog/inventor-portal) describes what it should show.
- Schedule meetings around clinic and theatre timetables.

## A worked example

**Illustration with invented figures.** A 1,200-bed teaching hospital receives 25 invention disclosures a year, mostly devices and diagnostic software.

| Task | Hours a year without linked records | Hours a year with linked records |
|---|---|---|
| Chasing ethics approval details for disclosures and due diligence | 120 | 30 |
| Settling ownership across affiliations after filing | 80 | 20 |
| Answering licensee questions on regulatory status | 100 | 40 |
| Locating MTAs and sample records | 60 | 15 |
| Total | 360 | 105 |

At an assumed staff cost of ₹1,000 an hour, the difference is ₹2,55,000 a year in TTO time alone. The bigger gain is fewer deals delayed while documents are found.

## Common mistakes

- Attaching patient records to invention disclosures.
- Filing in the hospital's name without checking the inventor's other affiliations and grants.
- Licensing to a company in which an inventor or relative has a stake, without disclosure and approval.
- Marketing a device technology without any view of its regulatory class.
- Using a patent docketing tool and keeping ethics, MTA and regulatory records elsewhere.

My view: in a hospital, the records around a patent are often worth more to a licensee than the patent itself, because they show the data was gathered properly and the regulatory path is understood. I am less certain how many Indian hospitals have a formal IP policy at all, since few publish one, so start by checking whether yours does.

For medical research institutes, [Zernyx IPMS](https://ipms.zernyxhub.com/) is an IP lifecycle management platform for universities and research institutions, to manage patents, filings and IP portfolios end to end.

## Common questions

### Why do hospitals need different IP management from universities?

Hospital inventions usually come from clinicians, often rest on patient data or samples, need ethics approvals, and many are medical devices or diagnostics that face regulatory licensing. An IP system for a hospital must link each invention to those records, not only to patent filings.

### Does patient data in an invention record raise legal issues?

It can. Under the Digital Personal Data Protection Act, 2023, whose duties for data fiduciaries apply from May 2027 under the DPDP Rules, 2025, a data fiduciary stays responsible for processing done on its behalf by a data processor, must take reasonable security safeguards, and must report personal data breaches. Keep identifiable patient data out of invention disclosures and IP records wherever possible.

### Who owns inventions made by doctors at a public hospital?

It depends on the institution's IP policy and the doctor's terms of employment. The AIIMS IPR Policy 2017, for example, vests IP made at AIIMS by its faculty and staff in AIIMS and shares income 70% to inventors and 30% to the institute after costs. Check your own institution's policy.

### What regulatory steps should a hospital IPMS track?

For devices, the classification and the licence route under the Medical Devices Rules, 2017: most Class A and B devices are licensed by the State Licensing Authority, and Class C and D by CDSCO. Tracking these alongside patents tells the TTO how far an invention is from market.

---

Published by Zernyx Hub. More: https://zernyxhub.com/llms.txt
